Nick Galakatos and the Black­stone team now have a record $4.6B to in­vest in bio­phar­ma, with a big fo­cus on push­ing com­pa­nies over the top

Nick Galakatos and his team at Black­stone Life Sci­ences have seen their biggest op­por­tu­ni­ties swell up in most­ly es­tab­lished play­ers who don’t have all the mon­ey they need to ac­com­plish every­thing on the to-do list. And right now, with the in­dus­try boom­ing, that’s a long list with some hefty needs.

The Black­stone team has neat­ly tied up the largest pri­vate fund ever raised in life sci­ences for mak­ing big dreams come true in bio­phar­ma. Late Thurs­day, Black­stone put out word that they had closed their high­ly an­tic­i­pat­ed fund with the pro­ject­ed $4.6 bil­lion all in.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER